Why Solventum Corporation’s (SOLV) Stock Is Up 7.63%
As of Tuesday, July 28, Solventum Corporation’s SOLV share price has surged by 7.63%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
Jenna Brashear
Tudor Pop
Jenna Brashear
Jenna Brashear
| Share Statistics | SOLV | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $15,035.0 | $334.8 | 83% |
|
| Shares Out (Mil) | 175.5 | 41.7 | 74% |
|
| Institutional Ownership | 99.7% | 77.3% | 93% |
|
| Float (Mil) | 147.1 | 34.7 | 69% |
|
| Beta | 0.72 | 0.86 | 42% |
|
| Avg Daily Volume (000s) | 1,116 | 266 | 73% |
|
| Price Change (52-week) |
18.0% | 60.7% | 60% |
|
| Growth | SOLV | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.7% | 11.8% | 26% |
|
| Net Income (5yr) | 6.5% | (5.8%) | 49% |
|
| EPS (5yr) | na | 10.7% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 11 | 15 | 15 | |
| Current EPS | $1.906 | $6.551 | $7.089 | |
| Month Ago EPS | $1.892 | $6.547 | $7.047 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $1.663 | $6.459 | $6.975 | |
| Year/Year Chg | 2,623% | (26.2%) | (12.8%) | |
| Financials | SOLV | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $8,262 | $152 | 82% |
|
| Net Income (TTM) (Mil) | $1,432 | ($11) | 90% |
|
| EPS (TTM) | $8.219 | ($0.500) | 93% |
|
| Operating Cash Flow (TTM) (Mil) | $151 | ($2) | 56% |
|
| Net Cash Flow (TTM) (Mil) | $21 | $1 | 63% |
|
| Long-Term Debt (Q1) (Mil) | $4,785 | $22 | 85% |
|
| Enterprise Value (Q1) (Mil) | $17,749 | $304 | 82% |
|
| Valuation | SOLV | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.03 | 2.88 | 65% |
|
| P/E | 10.6 | 30.5 | 18% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | SOLV | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 53.7% | 59.1% | 66% |
|
| Net Margin | 17.3% | (7.7%) | 76% |
|
| ROA | 10.0% | (13.7%) | 87% |
|
| ROE | 34.8% | (15.9%) | 89% |
|
| Liabilities to Assets | 64.8% | 44.9% | 60% |
|
| F-Score | 5 | 4 | 51% |
|
Solventum Corporation did not pass any screens on 7/30/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors